Myles Wolf

23PUBLICATIONS
56CO-AUTHORS
Molecular targetsInfant and child healthImmunogenetics (incl. genetic immunology)Clinical chemistry (incl. diagnostics)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 12, 2026
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.

Benjamin Catanese, Cameron Miller, Myles Wolf

|Feb 05, 2026
Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.

Farzana Perwad, Matthew B Matheson, Eva Glenn Lecea

|May 25, 2024
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.

Glenn M Chertow, Anna Marie Chang, G Michael Felker

|Jan 03, 2024
Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial.

Kalani L Raphael, Ronit Katz, Brett Larive

|Aug 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease.

Daniel Edmonston, Tamara Isakova, Myles Wolf

|Jul 14, 2023
FGF23 and klotho at the intersection of kidney and cardiovascular disease.

Daniel Edmonston, Alexander Grabner, Myles Wolf

Pageof 4

Frequent Collaborators

8 joint publications

Tamara Isakova

6 joint publications

Daniel Edmonston

4 joint publications

Glenn M Chertow

4 joint publications

Mark Heise